Form 8-K - Current report:
SEC Accession No. 0001558370-24-016118
Filing Date
2024-12-10
Accepted
2024-12-10 16:05:12
Documents
13
Period of Report
2024-12-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20241206x8k.htm   iXBRL 8-K 50289
  Complete submission text file 0001558370-24-016118.txt   175937

Data Files

Seq Description Document Type Size
2 EX-101.SCH mrns-20241206.xsd EX-101.SCH 3252
3 EX-101.LAB mrns-20241206_lab.xml EX-101.LAB 16590
4 EX-101.PRE mrns-20241206_pre.xml EX-101.PRE 10712
15 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20241206x8k_htm.xml XML 5063
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 241538472
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)